Skip Navigation


ToxSci Advance Access originally published online on May 26, 2006
Toxicological Sciences 2006 92(2):476-489; doi:10.1093/toxsci/kfl014
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Supplementary Data
Right arrow All Versions of this Article:
92/2/476    most recent
kfl014v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Vanden Heuvel, J. P.
Right arrow Articles by Gillies, P. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vanden Heuvel, J. P.
Right arrow Articles by Gillies, P. J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Differential Activation of Nuclear Receptors by Perfluorinated Fatty Acid Analogs and Natural Fatty Acids: A Comparison of Human, Mouse, and Rat Peroxisome Proliferator-Activated Receptor-{alpha}, -ß, and -{gamma}, Liver X Receptor-ß, and Retinoid X Receptor-{alpha}

John P. Vanden Heuvel*,1, Jerry T. Thompson*, Steven R. Frame{dagger} and Peter J. Gillies{dagger},{ddagger}

* Department of Veterinary and Biomedical Science and The Center for Molecular Toxicology and Carcinogenesis, The Pennsylvania State University, University Park, Pennsylvania 16802; {dagger} DuPont Haskell Laboratory for Health and Environmental Sciences, Newark, Delaware 19714; and {ddagger} Department of Nutritional Sciences, The Pennsylvania State University, University Park, Pennsylvania 16802

Received March 24, 2006; accepted May 1, 2006

Administration of ammonium salts of perfluorooctanoate (PFOA) to rats results in peroxisome proliferation and benign liver tumors, events associated with activation of the nuclear receptor (NR) peroxisome proliferator-activated receptor-{alpha} (PPAR{alpha}). Due to its fatty acid structure, PFOA may activate other NRs, such as PPARß, PPAR{gamma}, liver X receptor (LXR), or retinoid X receptor (RXR). In this study, the activation of human, mouse, and rat PPAR{alpha}, PPARß, PPAR{gamma}, LXRß, and RXR{alpha} by PFOA (including its linear and branched isomers) and perfluorooctane sulfonate (PFOS) was investigated and compared to several structural classes of natural fatty acids and appropriate positive control ligands. An NR ligand-binding domain/Gal4 DNA-binding domain chimeric reporter system was used. Human, mouse, and rat PPAR{alpha} were activated by PFOA isomers and PFOS. PPARß was less sensitive to the agents tested, with only PFOA affecting the mouse receptor. PFOA and PFOS also activated human, mouse, and rat PPAR{gamma}, although the maximum induction of PPAR{gamma} was much less than that seen with rosiglitazone, suggesting that PFOA and PFOS are partial agonists of this receptor. Neither LXRß nor the common heterodimerization partner RXR{alpha} was activated by PFOA in any species examined. Taken together, these data show that of the NRs studied, PPAR{alpha} is the most likely target of PFOA and PFOS, although PPAR{gamma} is also activated to some extent. Compared to naturally occurring long-chain fatty acids, e.g. linoleic and {alpha}-linolenic acids, these perfluorinated fatty acid analogs were more selective and less potent in their activation of the NRs.

Key Words: nuclear receptors; transactivation; dietary fatty acids; fatty acid analogs.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Toxicol SciHome page
X. Fang, L. Zhang, Y. Feng, Y. Zhao, and J. Dai
Immunotoxic Effects of Perfluorononanoic Acid on BALB/c Mice
Toxicol. Sci., October 1, 2008; 105(2): 312 - 321.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
K. P. Das, B. E. Grey, R. D. Zehr, C. R. Wood, J. L. Butenhoff, S.-C. Chang, D. J. Ehresman, Y.-M. Tan, and C. Lau
Effects of Perfluorobutyrate Exposure during Pregnancy in the Mouse
Toxicol. Sci., September 1, 2008; 105(1): 173 - 181.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
P. A. Davis, M. Jenab, J. P. Vanden Heuvel, T. Furlong, and S. Taylor
Tree Nut and Peanut Consumption in Relation to Chronic and Metabolic Diseases Including Allergy
J. Nutr., September 1, 2008; 138(9): 1757S - 1762S.
[Abstract] [Full Text] [PDF]


Home page
J DAIRY SCIHome page
M. Bionaz, C. R. Baumrucker, E. Shirk, J. P. Vanden Heuvel, E. Block, and G. A. Varga
Short Communication: Characterization of Madin-Darby Bovine Kidney Cell Line for Peroxisome Proliferator-Activated Receptors: Temporal Response and Sensitivity to Fatty Acids
J Dairy Sci, July 1, 2008; 91(7): 2808 - 2813.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
M. B. Rosen, B. D. Abbott, D. C. Wolf, J. C. Corton, C. R. Wood, J. E. Schmid, K. P. Das, R. D. Zehr, E. T. Blair, and C. Lau
Gene Profiling in the Livers of Wild-type and PPAR{alpha}-Null Mice Exposed to Perfluorooctanoic Acid
Toxicol Pathol, June 1, 2008; 36(4): 592 - 607.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
M. B. Rosen, J. S. Lee, H. Ren, B. Vallanat, J. Liu, M. P. Waalkes, B. D. Abbott, C. Lau, and J. C. Corton
Toxicogenomic Dissection of the Perfluorooctanoic Acid Transcript Profile in Mouse Liver: Evidence for the Involvement of Nuclear Receptors PPAR{alpha} and CAR
Toxicol. Sci., May 1, 2008; 103(1): 46 - 56.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
M. E. Andersen, J. L. Butenhoff, S.-C. Chang, D. G. Farrar, G. L. Kennedy Jr, C. Lau, G. W. Olsen, J. Seed, and K. B. Wallace
Perfluoroalkyl Acids and Related Chemistries--Toxicokinetics and Modes of Action
Toxicol. Sci., March 1, 2008; 102(1): 3 - 14.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
C. Lau, K. Anitole, C. Hodes, D. Lai, A. Pfahles-Hutchens, and J. Seed
Perfluoroalkyl Acids: A Review of Monitoring and Toxicological Findings
Toxicol. Sci., October 1, 2007; 99(2): 366 - 394.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
C. G. Woods, J. P. Vanden Heuvel, and I. Rusyn
Genomic Profiling in Nuclear Receptor-Mediated Toxicity
Toxicol Pathol, June 1, 2007; 35(4): 474 - 494.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
M. T. Martin, R. J. Brennan, W. Hu, E. Ayanoglu, C. Lau, H. Ren, C. R. Wood, J. C. Corton, R. J. Kavlock, and D. J. Dix
Toxicogenomic Study of Triazole Fungicides and Perfluoroalkyl Acids in Rat Livers Predicts Toxicity and Categorizes Chemicals Based on Mechanisms of Toxicity
Toxicol. Sci., June 1, 2007; 97(2): 595 - 613.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
M. L. Takacs and B. D. Abbott
Activation of Mouse and Human Peroxisome Proliferator-Activated Receptors ({alpha}, {beta}/{delta}, {gamma}) by Perfluorooctanoic Acid and Perfluorooctane Sulfonate
Toxicol. Sci., January 1, 2007; 95(1): 108 - 117.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.